408 related articles for article (PubMed ID: 34470916)
21. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
22. Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model.
Kong P; Yang H; Tong Q; Dong X; Yi MA; Yan D
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10685-10700. PubMed ID: 37306737
[TBL] [Abstract][Full Text] [Related]
23. Prognostic potential of PRPF3 in hepatocellular carcinoma.
Liu Y; Yang Y; Luo Y; Wang J; Lu X; Yang Z; Yang J
Aging (Albany NY); 2020 Jan; 12(1):912-930. PubMed ID: 31926109
[TBL] [Abstract][Full Text] [Related]
24. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365
[TBL] [Abstract][Full Text] [Related]
25. CD97 serves as a novel biomarker of immune cell infiltration in hepatocellular carcinoma.
Su Q; Li L; Li X; Li W; Zhang X; Dong Y; Han L; Wang D; Ran J
World J Surg Oncol; 2022 Dec; 20(1):382. PubMed ID: 36464675
[TBL] [Abstract][Full Text] [Related]
26. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
27. Highly expressed centromere protein L indicates adverse survival and associates with immune infiltration in hepatocellular carcinoma.
Zeng Z; Jiang X; Pan Z; Zhou R; Lin Z; Tang Y; Cui Y; Zhang E; Cao Z
Aging (Albany NY); 2021 Oct; 13(19):22802-22829. PubMed ID: 34607313
[TBL] [Abstract][Full Text] [Related]
28. TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
Jian F; Yanhong J; Limeng W; Guoping N; Yiqing T; Hao L; Zhaoji P
Int Immunopharmacol; 2022 Sep; 110():109008. PubMed ID: 35792273
[TBL] [Abstract][Full Text] [Related]
29. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
[TBL] [Abstract][Full Text] [Related]
30. LMNB2 is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
Kong W; Wu Z; Yang M; Zuo X; Yin G; Chen W
IUBMB Life; 2020 Dec; 72(12):2672-2685. PubMed ID: 33211382
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive analysis of the oncogenic and prognostic role of TBC1Ds in human hepatocellular carcinoma.
Zhang P; Zhu L; Pan X
PeerJ; 2024; 12():e17362. PubMed ID: 38766486
[TBL] [Abstract][Full Text] [Related]
32. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
[No Abstract] [Full Text] [Related]
33. EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
Shu Y; He L; Gao M; Xiao F; Yang J; Wang S; Wei H; Zhang F; Wei H
Front Immunol; 2021; 12():780509. PubMed ID: 35069551
[TBL] [Abstract][Full Text] [Related]
34. Correlation analysis of RDM1 gene with immune infiltration and clinical prognosis of hepatocellular carcinoma.
Qiu C; Li Z; Cao W; Cai X; Ye L; Zhang C; Ma Y; Wang X; Yang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34435618
[TBL] [Abstract][Full Text] [Related]
35. ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle.
Zhen J; Ke Y; Pan J; Zhou M; Zeng H; Song G; Yu Z; Fu B; Liu Y; Huang D; Wu H
Aging (Albany NY); 2022 Oct; 14(20):8411-8436. PubMed ID: 36287187
[TBL] [Abstract][Full Text] [Related]
36. CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma.
Wang Z; Chen S; Wang G; Li S; Qin X
Biomed Res Int; 2021; 2021():6622437. PubMed ID: 33604380
[TBL] [Abstract][Full Text] [Related]
37. Prognostic and immunological potential of PPM1G in hepatocellular carcinoma.
Lin YR; Yang WJ; Yang GW
Aging (Albany NY); 2021 May; 13(9):12929-12954. PubMed ID: 33952716
[TBL] [Abstract][Full Text] [Related]
38. ATP13A2 is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
Huang J; Xu S; Yu Z; Zheng Y; Yang B; Ou Q
J Gastrointest Surg; 2023 Jan; 27(1):56-66. PubMed ID: 36127552
[TBL] [Abstract][Full Text] [Related]
39. High HBXIP expression is related to poor prognosis in HCC by extensive database interrogation.
Guo ZY; Jiang LP; Zhu ZT
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6196-6207. PubMed ID: 34730200
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
